The timing of the initial public offering and the clearance of a new insulin pump are expected to affect Medtronic’s results for its 2026 fiscal year.
Medtronic lowers earnings forecast after MiniMed IPO
By Healthradar
By Healthradar
By Healthradar
The timing of the initial public offering and the clearance of a new insulin pump are expected to affect Medtronic’s results for its 2026 fiscal year.
